Real questions from health communities, answered with cited research from PubMed and Vellito's article corpus. Plain language, no medical advice. How this works.
For high-risk GIST patients, 5-year relapse-free survival is about 74% with ≤3 years of adjuvant imatinib and 84% with >3 years, based on a 2026 retrospective study.
Researchers expect to find that second-line drugs like trabectedin, pazopanib, and eribulin offer options after anthracycline failure, but consistent guidelines are still lacking…
Treatment with eltrombopag and immunosuppression leads to an increase in clonal mutations over time, with two main patterns of evolution: early changes involving chromosome 7 and…
After anthracycline failure, trabectedin and eribulin are standard second-line options, while pazopanib is also approved in some regions. Newer agents like repotrectinib are…
A high delta-NLR, which measures the rise in neutrophil-to-lymphocyte ratio during treatment, predicts a worse prognosis for soft tissue sarcoma patients compared to those whose…
Genome sequencing can find diagnoses for many undiagnosed genetic disorders in newborns, with overall success rates around 19% to 26% depending on the study and test type.
Preschoolers (4–6 years) had the highest burden of respiratory tract infections after COVID restrictions lifted, with a 68.3% pathogen detection rate.
Yes, adding regional hyperthermia to chemotherapy may improve survival for extremity soft tissue sarcoma, based on a post-hoc analysis of a randomized trial.
Exome sequencing finds a genetic cause in about 19% of prenatal cases, with higher rates for specific conditions like nonimmune hydrops fetalis.
Extracellular vesicles (EVs) offer a safer, cell-free way to treat premature ovarian insufficiency by restoring ovarian function without the risks of live cell transplants.
Yes, parechovirus A can cause pharyngitis and tonsillitis in hospitalized children, especially when detected alone without other viruses.
Yes, asthma significantly increases a preschooler's risk of recurrent respiratory tract infections, with meta-analysis showing about 3 times higher odds.
Yes, passive smoking is a significant risk factor that increases the likelihood of recurrent respiratory tract infections in young children.
Frequent snacks are linked to a higher risk of recurrent respiratory tract infections in preschoolers, according to a meta-analysis of global studies.
Proton pump inhibitors (PPIs) can cause drug-related problems in hospitalized patients with kidney disease, including issues with drug selection, treatment duration, and…
Having a fungal infection in your lungs does not automatically mean you have a bacterial infection, though both can occur together in certain conditions like HIV or COPD.
Yes, longitudinal TCR profiling can predict GVHD in stem cell transplant patients, with studies showing AUC values around 0.83 for GVHD prediction.
Researchers induce cardiometabolic disease in mice primarily by feeding them a high-fat diet, often combined with chemical treatments like VCD to mimic postmenopausal states.
In mice with diet-induced cardiometabolic disease, intermuscular fat tissue shows specific gene signatures involving inflammation, extracellular matrix changes, and metabolic…
Researchers use mice and rats with diet-induced obesity, heart attacks, or specific genetic changes to study cardiometabolic diseases like heart failure and diabetes.
The pooled overall complication rate for Thulium Fiber Laser lithotripsy is about 10.4%, with major complications (Clavien-Dindo III-V) occurring in about 1.2% of cases.
Cognitive remediation therapy (CRT) shows significant benefits over standard care for people with psychotic disorders, improving global functioning and quality of life.
Yes, a case report describes a patient with metastatic uveal melanoma who achieved durable disease control after adding SBRT to tebentafusp, with a partial response and 35 months…
Prolgolimab plus chemotherapy showed the strongest overall survival benefit in a 2025 phase III trial, while network meta-analysis also ranked pembrolizumab and cemiplimab plus…
We pull real patient questions from public Reddit health communities (r/AskDocs, r/diabetes, r/menopause, etc.). Each question is rewritten into a generic medical question (no personal details), then answered by an AI using only cited sources from Vellito's article database and PubMed. A second AI independently scores each answer for accuracy and citation fidelity before publication. Answers below the safety threshold or touching emergency, dosing, or pediatric topics are queued for human review and never auto-published.
This is not medical advice. Always speak with your own doctor before making decisions about your health.